| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry execu...
NeonMind Biosciences Inc. (CSE:NEON) (OTCQB: NMDBF) (FRA:6UF) plans to launch 10 specialty mental health clinics over the next ...
Psychedelic drug company NeonMind Biosciences Inc. (CSE:NEON)(OTCQB: NMDBF)(FRA:6UF) announced Thursday a strategic partnership...
Former Tilray Exec Ana Bowman Joins MedMen As CFO MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) has appointed Ana Bowman ...
NeonMind Biosciences Inc. (CSE: NEON)(OTCQB: NMDBF)(FRA:6UF) has appointed Dr. Dinesh Bhayana, MD, CCFP, as the site medical di...
The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking...
The Nasdaq welcomed its third psychedelics company this week, with the acquisition of MagicMed Industries by Enveric Bioscience...